Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the …

F De Rose, A Fogliata, D Franceschini, C Iftode… - The Breast, 2018 - Elsevier
Introduction To evaluate acute toxicity and cosmetic outcomes of hypofractionated
simultaneous integrated boost (SIB) as adjuvant treatment after breast-conserving surgery …

[HTML][HTML] Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts

A Montero, X Sanz, R Hernanz, D Cabrera, M Arenas… - The Breast, 2014 - Elsevier
The demand for breast cancer care has increased as cancer treatment innovations have
proliferated. Adjuvant radiotherapy to the breast is considered to be part of the standard …

A mathematical study to select fractionation regimen based on physical dose distribution and the linear–quadratic model

M Mizuta, S Takao, H Date, N Kishimoto… - International Journal of …, 2012 - Elsevier
PURPOSE: Hypofractionated irradiation is often used in precise radiotherapy instead of
conventional multifractionated irradiation. We propose a novel mathematical method for …

[HTML][HTML] Predictive factors associated with radiation dermatitis in breast cancer

T Behroozian, L Milton, N Li, L Zhang, J Lou… - Cancer Treatment and …, 2021 - Elsevier
Purpose Radiation dermatitis (RD) is a side effect that frequently arises during radiotherapy
(RT) in breast cancer patients. The present study investigates possible predictive factors of …

NTCP models for severe radiation induced dermatitis after IMRT or proton therapy for thoracic cancer patients

G Palma, S Monti, M Conson, T Xu, S Hahn… - Frontiers in …, 2020 - frontiersin.org
Radiation therapy (RT) of thoracic cancers may cause severe radiation dermatitis (RD),
which impacts on the quality of a patient's life. Aim of this study was to analyze the incidence …

Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy

MC De Santis, F Bonfantini, F Di Salvo, M Dispinzieri… - The breast, 2016 - Elsevier
Purpose To evaluate toxicity in breast cancer patients treated with anthracycline and taxane
based chemotherapy and whole breast hypofractionated radiotherapy, and to identify the …

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results

F De Rose, A Fogliata, D Franceschini, P Navarria… - Radiation …, 2016 - Springer
Background To report toxicity and early clinical outcomes of hypofractionated simultaneous
integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant …

Changes in biophysical properties of the skin following radiotherapy for breast cancer

SCS Hu, MF Hou, KH Luo, HY Chuang… - The Journal of …, 2014 - Wiley Online Library
Acute radiation dermatitis is a common adverse effect in patients undergoing radiotherapy
for breast cancer. However, the effects of radiotherapy on biophysical properties of the skin …

Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound

V Landoni, C Giordano, A Marsella, B Saracino… - Journal of Experimental …, 2013 - Springer
Background Feasibility of whole breast hypofractionated radiotherapy schedules in breast
conserving therapy is recognized however concerns remain about the role of the boost dose …

Hypofractionated radiotherapy for breast cancers-preliminary results from a tertiary care center in eastern India

M Nandi, A Mahata, I Mallick, R Achari… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The standard radiotherapy (RT) fractionation practiced in India and worldwide
is 50Gy in 25 fractions over 5 weeks to the chest wall or whole breast followed by tumour …